Form 6-K GALAPAGOS NV For: Jan 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
25,200€
0,80%
Echtzeit-Aktienkurs Galapagos N.V. (ADRs)
Bid:
Ask:
Nachrichten zur Galapagos N.V. (ADRs) Aktie
Galapagos receives transparency notification from FMR LLC
Mechelen, Belgium; 10 January 2023, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification…
Form 6-K GALAPAGOS NV For: Jan 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K GALAPAGOS NV For: Dec 23
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Galapagos receives transparency notification from FMR LLC
Mechelen, Belgium; 23 December 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification…
Form 6-K GALAPAGOS NV For: Dec 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Galapagos announces changes to executive committee
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Galapagos announces changes to Executive Committee
Mechelen, Belgium; 22 December 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced changes in the Executive Committee…
Major Discovery Gives Hope for Saving Critically Endangered Pink Iguana
The first-ever nesting area of the Pink Iguana and, nearby, photographed the first Pink Iguana hatchlings ever observed have been…
Endangered pink iguana hatchlings seen for first time on Galapagos island
...QUITO (Reuters) - Scientists have discovered hatchling......…
On A Mission As Top European Player, Galapagos Looks For Acquisition Targets
Galapagos NV (NASDAQ: GLPG) is reportedly looking for M&A deals with companies with products still in the preclinical or early stage…
Does Galapagos NV (GLPG) Have the Potential to Rally 34% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 34.4% in Galapagos NV (GLPG).…
Form 6-K GALAPAGOS NV For: Dec 13
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
Mechelen, Belgium; 13 December 2022, 7.00 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and CellPoint (a Galapagos company) today presented…
Brazil Hedge Fund Galapagos to Start US Fund in 2023, CIO Says
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bankers bet billions on new wave of debt-for-nature deals
... (Reuters) - The Galapagos Islands, whose thousands of unique... Reuters: "Lots of my members are…
Galapagos downgraded to market perform at Raymond James on unclear path forward
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
Webcast replay available at www.glpg.com...…
Galapagos GAAP EPS of -€0.16, revenue of €410.2M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insights into the Rheumatoid Arthritis (RA) Online Space, 2022 Report Featuring UCB, Galapagos, BMS, Amgen, Pfizer, Sanofi, AbbVie, Genentech, Janssen, & Eli Lilly
DUBLIN, Oct. 26, 2022 /PRNewswire/ -- The "Rheumatoid Arthritis (RA) Therapy Area Report" report has been added to ResearchAndMarkets.coms offering.…
Form 6-K GALAPAGOS NV For: Oct 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Galapagos to host its R&D Update 2022 in New York on 4 November 2022
Mechelen, Belgium; 17 October 2022, 07.30 CET; - Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will host…
Form 6-K GALAPAGOS NV For: Oct 06
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
Type II variation1 regulatory application to amend the European label of Jyseleca® (filgotinib) based on data from MANTA and MANTA-RAy…